Header Logo

Katherine Ruiz De Luzuriaga

Concepts (251)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV-1
34
2022
705
5.970
Why?
HIV Infections
38
2022
920
5.750
Why?
Herpesvirus 4, Human
19
2020
181
3.460
Why?
Anti-Retroviral Agents
14
2019
73
2.580
Why?
Infectious Disease Transmission, Vertical
14
2020
71
2.370
Why?
Infectious Mononucleosis
10
2017
35
1.800
Why?
CD8-Positive T-Lymphocytes
12
2020
646
1.710
Why?
Anti-HIV Agents
8
2020
154
1.700
Why?
DNA, Viral
12
2020
228
1.690
Why?
Proviruses
5
2021
23
1.580
Why?
Epstein-Barr Virus Infections
6
2019
90
1.420
Why?
Genetic Variation
7
2021
364
1.210
Why?
Receptors, Antigen, T-Cell
6
2021
279
1.190
Why?
Viral Load
15
2022
229
1.180
Why?
RNA, Viral
9
2020
264
1.100
Why?
Viral Matrix Proteins
5
2017
51
1.090
Why?
B-Lymphocytes
8
2016
550
1.060
Why?
CD4-Positive T-Lymphocytes
7
2019
608
1.050
Why?
Immunologic Memory
9
2017
276
1.050
Why?
HIV Antibodies
7
2020
141
0.990
Why?
Antiretroviral Therapy, Highly Active
9
2020
94
0.950
Why?
Virus Latency
7
2019
28
0.930
Why?
Infant
21
2020
1522
0.890
Why?
Brain
4
2021
1487
0.840
Why?
HIV Seropositivity
1
2022
82
0.770
Why?
Phylogeny
9
2022
332
0.770
Why?
Pregnancy Complications, Infectious
4
2017
62
0.740
Why?
Secondary Prevention
3
2016
153
0.710
Why?
Antigens, Viral
3
2020
131
0.710
Why?
Vaccines
1
2022
97
0.710
Why?
Immunodominant Epitopes
3
2020
57
0.710
Why?
Spleen
1
2021
485
0.690
Why?
env Gene Products, Human Immunodeficiency Virus
4
2018
56
0.660
Why?
Receptors, Antigen, T-Cell, alpha-beta
2
2020
112
0.640
Why?
Adolescent
21
2022
5917
0.600
Why?
Humans
59
2022
59454
0.590
Why?
Viral Tropism
3
2018
55
0.560
Why?
Recombination, Genetic
2
2020
236
0.550
Why?
Infant, Newborn
12
2022
1306
0.540
Why?
Sequence Analysis, DNA
8
2021
397
0.530
Why?
Virus Replication
7
2017
302
0.520
Why?
Influenza A virus
4
2017
117
0.520
Why?
Virus Integration
1
2016
32
0.510
Why?
HIV Envelope Protein gp120
3
2018
139
0.510
Why?
Macrophages
5
2022
1004
0.500
Why?
Immunotherapy
2
2021
231
0.500
Why?
Epitopes, T-Lymphocyte
5
2019
177
0.490
Why?
Leukocytes, Mononuclear
7
2020
237
0.470
Why?
Child, Preschool
12
2020
1838
0.460
Why?
Oropharynx
1
2014
12
0.450
Why?
CD4 Antigens
2
2018
156
0.440
Why?
Immunoglobulin G
4
2020
452
0.410
Why?
T-Lymphocytes, Cytotoxic
3
2019
165
0.370
Why?
AIDS Vaccines
3
2012
67
0.360
Why?
Viremia
3
2015
44
0.360
Why?
Antibodies, Viral
3
2022
305
0.360
Why?
HIV Envelope Protein gp41
1
2020
22
0.350
Why?
Pregnancy
8
2017
2354
0.340
Why?
Genome, Viral
2
2018
120
0.340
Why?
Software
2
2021
367
0.330
Why?
Major Histocompatibility Complex
1
2020
86
0.330
Why?
Immediate-Early Proteins
1
2019
44
0.330
Why?
Complementarity Determining Regions
1
2019
37
0.330
Why?
Genes, env
3
2021
15
0.330
Why?
Female
26
2020
30893
0.320
Why?
HIV
1
2019
69
0.310
Why?
Trans-Activators
1
2019
295
0.290
Why?
CD4 Lymphocyte Count
5
2017
92
0.290
Why?
Nervous System Diseases
1
2018
97
0.280
Why?
Genes, Immunoglobulin
2
2007
32
0.270
Why?
Antibodies, Neutralizing
2
2018
191
0.270
Why?
Acquired Immunodeficiency Syndrome
1
2017
137
0.270
Why?
High-Throughput Nucleotide Sequencing
3
2021
251
0.270
Why?
Receptors, CCR5
3
2018
57
0.270
Why?
Influenza, Human
1
2017
193
0.250
Why?
Child
7
2020
4307
0.240
Why?
Mutation
6
2017
2443
0.230
Why?
Cytomegalovirus Infections
1
2015
69
0.230
Why?
HLA-A2 Antigen
4
2019
65
0.230
Why?
Molecular Sequence Data
6
2014
1973
0.230
Why?
Male
19
2020
27556
0.220
Why?
Membrane Glycoproteins
1
2016
667
0.220
Why?
Evolution, Molecular
1
2015
291
0.220
Why?
Adult
16
2018
15767
0.210
Why?
Meninges
1
2022
10
0.210
Why?
Disease Reservoirs
1
2012
8
0.210
Why?
Transcriptome
1
2015
329
0.200
Why?
Young Adult
6
2019
4320
0.200
Why?
Cluster Analysis
2
2021
250
0.200
Why?
Amino Acids
1
2022
140
0.190
Why?
Infant, Newborn, Diseases
1
2011
33
0.190
Why?
Cross Reactions
3
2017
123
0.190
Why?
Hepatitis B Vaccines
1
2010
13
0.170
Why?
Amino Acid Sequence
4
2019
1576
0.170
Why?
Proteomics
1
2022
255
0.170
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2009
525
0.170
Why?
Hepatitis B
1
2010
28
0.170
Why?
Acute Disease
4
2016
658
0.170
Why?
Sustained Virologic Response
2
2020
10
0.170
Why?
T-Lymphocytes
2
2022
964
0.170
Why?
Apoptosis Regulatory Proteins
1
2010
148
0.170
Why?
AIDS Serodiagnosis
1
2009
19
0.160
Why?
Drug Therapy, Combination
3
2016
432
0.160
Why?
Antigens, CD
1
2010
343
0.160
Why?
Enzyme-Linked Immunosorbent Assay
3
2020
448
0.160
Why?
Time Factors
5
2014
3578
0.150
Why?
HIV Core Protein p24
1
2008
17
0.150
Why?
HIV Antigens
1
2008
20
0.150
Why?
Peptide Fragments
3
2019
349
0.150
Why?
Computational Biology
2
2021
325
0.150
Why?
gag Gene Products, Human Immunodeficiency Virus
1
2008
36
0.150
Why?
Models, Immunological
1
2007
79
0.140
Why?
Base Sequence
4
2016
1311
0.130
Why?
Lymphocyte Activation
4
2017
739
0.130
Why?
Orthomyxoviridae
1
2005
26
0.130
Why?
Early Medical Intervention
1
2015
17
0.120
Why?
Milk, Human
1
2006
94
0.120
Why?
Viral Vaccines
1
2015
49
0.120
Why?
Computer Simulation
1
2007
457
0.120
Why?
Lymphocytes
1
2005
193
0.120
Why?
Genotype
3
2018
636
0.120
Why?
Gene Expression
4
2018
807
0.110
Why?
Reverse Transcriptase Inhibitors
2
2002
28
0.110
Why?
nef Gene Products, Human Immunodeficiency Virus
2
2019
20
0.110
Why?
B-Lymphocyte Subsets
1
2003
48
0.110
Why?
Pediatrics
1
2006
266
0.110
Why?
Mothers
3
2015
261
0.110
Why?
Treatment Outcome
5
2016
5174
0.110
Why?
Burkitt Lymphoma
1
2003
56
0.110
Why?
Seroepidemiologic Studies
1
2022
48
0.100
Why?
Bayes Theorem
1
2022
106
0.100
Why?
Neonatal Screening
1
2022
96
0.100
Why?
Interferon-gamma
2
2017
542
0.090
Why?
HIV Envelope Protein gp160
1
2020
6
0.090
Why?
Flow Cytometry
3
2018
638
0.090
Why?
Neutralization Tests
2
2018
125
0.090
Why?
Cohort Studies
3
2019
2443
0.080
Why?
Poxviridae
1
2009
5
0.080
Why?
Cell Proliferation
3
2010
942
0.080
Why?
Longitudinal Studies
2
2016
1225
0.080
Why?
DNA, Complementary
2
2012
166
0.080
Why?
pol Gene Products, Human Immunodeficiency Virus
1
2019
4
0.080
Why?
Retrospective Studies
2
2022
6007
0.080
Why?
Polymerase Chain Reaction
1
2020
498
0.080
Why?
Receptors, Virus
1
2018
82
0.080
Why?
Puerto Rico
1
2019
228
0.080
Why?
Immunity, Heterologous
1
2017
11
0.070
Why?
Open Reading Frames
1
2018
82
0.070
Why?
Seroconversion
1
2017
4
0.070
Why?
Blood-Brain Barrier
1
2017
82
0.070
Why?
Convalescence
1
2016
17
0.070
Why?
Virion
1
2017
116
0.070
Why?
Primary Cell Culture
1
2016
75
0.070
Why?
Infant Mortality
1
2016
19
0.060
Why?
Sequence Alignment
1
2016
290
0.060
Why?
DNA Copy Number Variations
1
2016
65
0.060
Why?
Receptors, Interleukin-7
1
2015
16
0.060
Why?
Remission Induction
1
2016
137
0.060
Why?
ADP-ribosyl Cyclase 1
1
2015
29
0.060
Why?
Developing Countries
1
2016
84
0.060
Why?
Time-to-Treatment
1
2016
100
0.060
Why?
Phagocytosis
1
2016
252
0.060
Why?
Genomics
1
2018
314
0.060
Why?
Monocytes
1
2016
345
0.060
Why?
Host-Pathogen Interactions
1
2016
238
0.060
Why?
Epitopes
2
2005
295
0.060
Why?
Cytomegalovirus
1
2015
88
0.060
Why?
In Vitro Techniques
2
2005
472
0.060
Why?
Breast Feeding
1
2016
138
0.060
Why?
Case-Control Studies
1
2016
1055
0.060
Why?
Chronic Disease
1
2016
736
0.050
Why?
Lopinavir
1
2012
5
0.050
Why?
Severity of Illness Index
1
2017
1448
0.050
Why?
Cell Line, Tumor
1
2016
1373
0.050
Why?
Ritonavir
1
2012
14
0.050
Why?
Antibodies
1
2012
176
0.050
Why?
Risk
1
2012
373
0.050
Why?
Vaccines, Synthetic
1
2011
68
0.050
Why?
Cell Line
2
2018
2013
0.050
Why?
HIV Protease Inhibitors
1
2012
106
0.050
Why?
Autoimmune Diseases
1
2012
222
0.040
Why?
Clone Cells
1
2010
106
0.040
Why?
United States
2
2019
7515
0.040
Why?
Pharyngitis
1
2010
12
0.040
Why?
Programmed Cell Death 1 Receptor
1
2010
56
0.040
Why?
Hepatitis B Antibodies
1
2010
8
0.040
Why?
Streptococcus pyogenes
1
2010
27
0.040
Why?
Hepatitis B Surface Antigens
1
2010
16
0.040
Why?
HEK293 Cells
1
2012
575
0.040
Why?
Oligopeptides
1
2010
130
0.040
Why?
Streptococcal Infections
1
2010
77
0.040
Why?
Up-Regulation
1
2010
363
0.040
Why?
Vaccination
1
2011
337
0.040
Why?
Adrenal Cortex Hormones
1
2010
154
0.040
Why?
Receptors, CXCR4
1
2018
32
0.040
Why?
Virus Physiological Phenomena
1
2007
7
0.040
Why?
Palatine Tonsil
1
2007
10
0.040
Why?
Immunoglobulin D
1
2007
7
0.040
Why?
Virus Activation
1
2007
24
0.040
Why?
Tumor Necrosis Factor Receptor Superfamily, Member 7
1
2007
23
0.040
Why?
Stochastic Processes
1
2007
26
0.040
Why?
Transcription Factors
1
2015
1456
0.040
Why?
Middle Aged
2
2017
16256
0.040
Why?
Immunoglobulin M
1
2007
112
0.040
Why?
Diagnosis, Differential
1
2010
904
0.040
Why?
Antiviral Agents
1
2010
314
0.040
Why?
Cytotoxicity, Immunologic
1
2007
142
0.040
Why?
Mutagenesis
1
2007
129
0.030
Why?
Amino Acid Substitution
1
2008
252
0.030
Why?
Protein Multimerization
1
2018
167
0.030
Why?
Africa South of the Sahara
1
2006
17
0.030
Why?
Genetic Vectors
1
2012
813
0.030
Why?
HeLa Cells
1
2008
526
0.030
Why?
Genes, nef
1
2005
6
0.030
Why?
Macrophage Inflammatory Proteins
1
2005
11
0.030
Why?
Chemokine CCL4
1
2005
14
0.030
Why?
Genes, gag
1
2005
11
0.030
Why?
Transfection
1
2008
674
0.030
Why?
Cells, Cultured
1
2010
2099
0.030
Why?
Gene Products, nef
1
2005
14
0.030
Why?
Genes, MHC Class I
1
2005
28
0.030
Why?
K562 Cells
1
2005
58
0.030
Why?
Gene Products, gag
1
2005
65
0.030
Why?
Selection, Genetic
1
2005
69
0.030
Why?
DNA Primers
1
2005
291
0.030
Why?
Sequence Homology, Amino Acid
1
2005
357
0.030
Why?
RNA Stability
1
2015
93
0.030
Why?
Reproducibility of Results
1
2009
1551
0.030
Why?
Recombinant Proteins
1
2006
692
0.030
Why?
Epstein-Barr Virus Nuclear Antigens
1
2003
18
0.030
Why?
Immunophenotyping
1
2004
185
0.030
Why?
Genes, Viral
1
2003
56
0.030
Why?
Dose-Response Relationship, Drug
1
2005
796
0.030
Why?
Withholding Treatment
1
2013
38
0.030
Why?
Chi-Square Distribution
1
2004
401
0.030
Why?
Protein Binding
1
2018
1548
0.030
Why?
Recurrence
1
2015
577
0.030
Why?
Drug Resistance, Viral
1
2004
155
0.030
Why?
Cell Division
1
2003
442
0.030
Why?
Prevalence
1
2006
1284
0.030
Why?
Peptides
1
2005
545
0.020
Why?
Prospective Studies
1
2009
3096
0.020
Why?
Logistic Models
1
2004
1252
0.020
Why?
Age Factors
1
2014
1516
0.020
Why?
Phenotype
1
2003
1150
0.020
Why?
Follow-Up Studies
1
2015
2327
0.020
Why?
Immunization
1
2009
127
0.020
Why?
Models, Biological
1
2003
1141
0.020
Why?
Cross-Sectional Studies
1
2014
2473
0.020
Why?
Risk Factors
1
2014
5010
0.010
Why?
Animals
1
2006
19646
0.010
Why?
Ruiz De Luzuriaga's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (251)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_